Merck & Co

China sales, Singulair drive Merck’s Q1-2012 net to $3 bn

28 Apr 2012

Merck's worldwide sales for the first quarter of 2012 rose just one per cent to $11.7 billion due to the unfavorable impact from the arbitration settlement agreement with Johnson & Johnson

Merck, Brazil’s Supera Farma to form JV for generic drugs

16 Feb 2012

Merck to pay $950 million to settle Vioxx drug charges

24 Nov 2011

Vioxx was the centre of a long-running probe by the DoJ for Merck having promoted the painkiller without approval

Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million

29 Sep 2011

Merck & Co to axe 13,000 more jobs by 2015

30 Jul 2011

The second largest drug maker in the US, Merck & Co, hopes to save nearly $4.6 billion through this restructuring, amid slower revenue growth in the US and Europe

Sun to co market Merck's Diabetes drugs in India

25 Apr 2011

Merck, Sanofi Pasteur start Phase-3 trials of paediatric combination vaccine in US

23 Apr 2011

Merck, Sun Pharma in generics JV

11 Apr 2011

The joint venture will develop and commercialise novel formulations and combinations of medicines in emerging markets

Merck hopes to be among top-five drugmakers in India

11 Mar 2011

US drug major Merck is looking at catching up with its rivals including Glaxo Smith-Kleing (GSK) and Abbott to be among the top five players in India

Merck and Ranbaxy end drug development pact

06 Jan 2011

Merck to buy diabetes drug developer SmartCells in a $500 million-plus deal

03 Dec 2010

Merck aims for top slots in seven emerging markets

15 Nov 2010

Merck enters drug distribution pact with South Africa's Adcock Ingram

24 Jun 2010

Merck settles Zetia patent suit with Glenmark

11 May 2010

Battelle, IBM, Merck join UPMC’s effort to produce vaccines

12 Mar 2010

Merck receives EC approval for infertility treatment drug Elnova

28 Jan 2010

Former CDC chief Dr. Julie Gerberding appointed president of Merck Vaccines

22 Dec 2009

Merck wins summary judgment in Vioxx lawsuit in Texas

23 Nov 2009

Merck voluntarily withdrew Vioxx in September 2004 after a study showed the drug doubled the risk of heart attack or stroke

Merck receives FDA approval for new fertility drug for women

21 Nov 2009

Merck - Schering-Plough merger approved bu US, Swiss and Canadian regulators

30 Oct 2009

Merck & Co gets exclusive US rights for Afluria from CSL Biotherapies

29 Sep 2009

Merck, Wellcome Trust tie up to make affordable drugs in India

19 Sep 2009

US pharma giant Merck and British research charity Wellcome Trust have announced plans for a joint venture in India for developing "affordable" vaccines for poor countries.

Judge declares mistrial in Merck's Fosamax case

12 Sep 2009

Merck wins court ruling on Singulair patent

20 Aug 2009

Merck, Schering-Plough shareholders approve $41-billion deal

10 Aug 2009